BIIB080 clinical trials

A Study to Learn About the Safety of BIIB080 Injections and Whether They Can Improve Symptoms of Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD Dementia Between 50 to 80 Years of Age

This study is looking at a new medicine called BIIB080 for people with early Alzheimer's disease. Researchers want to see if it's safe and if it can slow down memory and thinking problems. They're also comparing different doses to a dummy medicine.